Our Blog

CREATES Act Hopes to Spur Generic Competition in Pharmaceutical Market

June 11, 2019
With the CREATES Act’s recent passage through Congress, generic manufacturers may soon have an easier time bringing those drugs to market. Click below to read more about the potential pros and cons...
Read More

Cigna’s Initiative to Lower the Out-Of-Pocket Cost of Insulin

April 22, 2019
Due to public pressure, the health insurance giant, Cigna, has announced they will lower the monthly out of pocket cost of insulin for participating patients from an average of $40 to no more than $25...
Read More

The Four Key Elements of Successful New Product Planning

April 12, 2019
New product planning is the nexus point between development and commercial planning. It's where you define the opportunity and set the stage for marketing the brand. Read our most recent white paper b...
Read More

Celebrating International Women’s Day

March 8, 2019
Happy Women’s Day!  International Women’s Day is a global day to celebrate the social, economic, cultural, and political achievements of women.  We are fortunate to have many hard working, high ...
Read More

Innovative Drug Pricing via “Netflix Model”

March 1, 2019
Louisiana seeks “Netflix model” for hepatitis C drug pricing In January 2019, the Louisiana Department of Health sent out a solicitation seeking a pharmaceutical manufacturer partner on a ...
Read More

Planning for 505(b)2 Commercial Success

October 17, 2018
Unlike generics and biosimilars, 505(b)2 regulatory products likely involve a unique claim. While 505(b)2 asset approval relies on reference product core clinical program data, ideal 505(b)2 candidate...
Read More

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

February 12, 2018
The impact of drug shortages is not new within the healthcare system, particularly at the hospital level, nor is the cost of drugs, however Fed Up with Drug Companies, Hospitals Decide to Start Their ...
Read More

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

January 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product lifecycle management” but are fast becoming obsolete options due to mounting FDA resistance. A rec...
Read More

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic dermatitis. One of the most highly-anticipated approvals of 2017, Dupixent is the latest output ...
Read More

Why Drug Pricing is in the News Now and What Can Be Done About It?

March 3, 2017
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan, there has been no shortage of news coverage on the high cost of prescription drugs. While polit...
Read More